Page last updated: 2024-08-24

irinotecan and niclosamide

irinotecan has been researched along with niclosamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cho, WCS; To, KKW; Tong, CWS; Wu, MM; Yan, VW; Zhang, Z	1

Other Studies

1 other study(ies) available for irinotecan and niclosamide

Article	Year
Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancer. Life sciences, 2020, Dec-01, Volume: 262 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Repositioning; Drug Synergism; HCT116 Cells; HT29 Cells; Humans; Irinotecan; Niclosamide; Signal Transduction; STAT3 Transcription Factor; Time Factors	2020

Article

Year

Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancer.

Life sciences, 2020, Dec-01, Volume: 262

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Repositioning; Drug Synergism; HCT116 Cells; HT29 Cells; Humans; Irinotecan; Niclosamide; Signal Transduction; STAT3 Transcription Factor; Time Factors

2020